Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Every CFTR variant counts - Target-capture based next-generation-sequencing for molecular diagnosis in the German CF Registry.
J Cyst Fibros. 2023 Oct 20:S1569-1993(23)00928-1. doi: 10.1016/j.jcf.2023.10.009. Online ahead of print.
J Cyst Fibros. 2023.
PMID: 37867076
Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry.
Sutharsan S, Dillenhoefer S, Welsner M, Stehling F, Brinkmann F, Burkhart M, Ellemunter H, Dittrich AM, Smaczny C, Eickmeier O, Kappler M, Schwarz C, Sieber S, Naehrig S, Naehrlich L; German CF Registry of the Mukoviszidose e.V. and participating CF sites.
Sutharsan S, et al.
Lancet Reg Health Eur. 2023 Jul 28;32:100690. doi: 10.1016/j.lanepe.2023.100690. eCollection 2023 Sep.
Lancet Reg Health Eur. 2023.
PMID: 37554663
Free PMC article.
Item in Clipboard
Isotope dilution LC-MS/MS quantification of the cystic fibrosis transmembrane conductance regulator (CFTR) modulators ivacaftor, lumacaftor, tezacaftor, elexacaftor, and their major metabolites in human serum.
Habler K, Kalla AS, Rychlik M, Bruegel M, Teupser D, Nährig S, Vogeser M, Paal M.
Habler K, et al. Among authors: nahrig s.
Clin Chem Lab Med. 2021 Oct 20;60(1):82-91. doi: 10.1515/cclm-2021-0724. Print 2022 Jan 26.
Clin Chem Lab Med. 2021.
PMID: 34668357
Item in Clipboard
Lung disease in STAT3 hyper-IgE syndrome requires intense therapy.
Kröner C, Neumann J, Ley-Zaporozhan J, Hagl B, Meixner I, Spielberger BD, Dückers G, Belohradsky BH, Niehues T, Borte M, Rosenecker J, Kappler M, Nährig S, Reu S, Griese M, Renner ED.
Kröner C, et al. Among authors: nahrig s.
Allergy. 2019 Sep;74(9):1691-1702. doi: 10.1111/all.13753. Epub 2019 Apr 4.
Allergy. 2019.
PMID: 30793327
Item in Clipboard
Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosis.
Hofer TP, Frankenberger M, Heimbeck I, Burggraf D, Wjst M, Wright AK, Kerscher M, Nährig S, Huber RM, Fischer R, Ziegler-Heitbrock L.
Hofer TP, et al. Among authors: nahrig s.
J Mol Med (Berl). 2014 Dec;92(12):1293-304. doi: 10.1007/s00109-014-1200-z. Epub 2014 Aug 23.
J Mol Med (Berl). 2014.
PMID: 25146850
Item in Clipboard
Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial.
Assael BM, Pressler T, Bilton D, Fayon M, Fischer R, Chiron R, LaRosa M, Knoop C, McElvaney N, Lewis SA, Bresnik M, Montgomery AB, Oermann CM; AZLI Active Comparator Study Group.
Assael BM, et al.
J Cyst Fibros. 2013 Mar;12(2):130-40. doi: 10.1016/j.jcf.2012.07.006. Epub 2012 Sep 15.
J Cyst Fibros. 2013.
PMID: 22985692
Free article.
Clinical Trial.
Item in Clipboard
[Cystic fibrosis care in transition from adolescence to adult age].
Fischer R, Nährig S, Kappler M, Griese M.
Fischer R, et al. Among authors: nahrig s.
Internist (Berl). 2009 Oct;50(10):1213-4, 1216, 1218-20. doi: 10.1007/s00108-009-2399-6.
Internist (Berl). 2009.
PMID: 19714300
Review.
German.
Item in Clipboard
Cite
Cite